Healthcare Services

Mycoplasma Testing Market Expected to Record Steady Growth and Approach $2.09 Billion by 2030

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Mycoplasma Testing Market Over The 2026–2030 Period?

The mycoplasma testing market has seen rapid expansion in recent years. Projections indicate it will expand from $1.23 billion in 2025 to reach $1.38 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 12.1%. Historically, this growth has been driven by factors such as the high incidence of mycoplasma contamination, a greater dependence on cell culture testing, an increase in demand for diagnostic testing, the early integration of PCR methods, and the growing application of ELISA techniques.

The mycoplasma testing market is projected to experience significant expansion in the coming years, with its size forecast to reach $2.1 billion by 2030 at a compound annual growth rate (CAGR) of 11.1%. This anticipated growth can be attributed to several factors, including the expansion of biopharmaceutical manufacturing, an increase in CRO outsourcing, greater investment in genomic testing, a heightened regulatory emphasis on contamination control, and the adoption of automated testing platforms. Additionally, key trends in the forecast period are expected to involve the growing acceptance of PCR-based mycoplasma detection, a greater reliance on rapid test kits for cell culture screening, an escalating demand for automated mycoplasma detection systems, the expanded application of assays and reagents in biopharmaceutical production, and an increased requirement for mycoplasma testing within research and CRO settings.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4103&type=smp

What Drivers Are Expected To Influence The Mycoplasma Testing Market During The Forecast Period?

The rising occurrence of mycoplasma pneumonia is anticipated to boost the expansion of the mycoplasma testing market moving ahead. This condition, mycoplasma pneumonia, is a respiratory infection stemming from the bacterium Mycoplasma pneumoniae. Mycoplasma testing is vital for diagnosing Mycoplasma pneumonia, as it functions by identifying Mycoplasma pneumoniae bacteria within respiratory samples, thereby assisting in the prompt and precise detection of the infection to facilitate suitable medical intervention and care. To illustrate, in December 2023, the Centers for Disease Control and Prevention, a US-based government agency, reported approximately 2 million annual cases of Mycoplasma pneumoniae infections in the United States. Consequently, the growing incidence of mycoplasma pneumonia is stimulating the expansion of the mycoplasma testing market.

How Is The Mycoplasma Testing Market Segmented Across Key Categories?

The mycoplasma testing market covered in this report is segmented –

1) By Product: Instruments, Assay, Kits, Reagents

2) By Technology: PCR, Elisa, Enzymatic Methods, DNA Staining, Other Technologies

3) By Application: Cell Line Testing, Virus Testing, End- Of- Production Cell Testing

4) By End User: Pharmaceutical & Biotechnology Companies, Cell Banks And Laboratories, Contract Research Organizations, Academic Research Institutes

Subsegments:

1) By Instruments: Mycoplasma Detection Systems, Automated Test Equipment, PCR Equipment

2) By Assay: Mycoplasma Assays, Qualitative Assays, Quantitative Assays

3) By Kits: Mycoplasma Detection Kits, Mycoplasma Testing Kits For Cell Cultures, Sample Preparation Kits

4) By Reagents: Nucleic Acid Reagents, Cell Culture Reagents, Staining Reagents

What Key Trends Are Influencing The Development Of The Mycoplasma Testing Market?

Leading companies in the mycoplasma testing market are increasingly concentrating on introducing digital PCR kits to gain a competitive advantage. Digital PCR kits are molecular biology tools that enable precise quantification and analysis of nucleic acids, such as DNA or RNA, through a digital method. For instance, in November 2023, QIAGEN, a Germany-based diagnostics company, unveiled three new QIAcuity digital PCR kits and enhanced software, broadening the scope of digital PCR applications in biopharmaceutical research and food safety. The new QIAcuity kits are engineered for precise quantification and are offered in one, four, and eight-plate versions; the one-plate version can process as many as 384 samples during an eight-hour shift. The QIAcuity Mycoplasma Quant Kit is one of these newly launched kits, providing researchers with an accurate and precise method to detect mycoplasma contaminants at every stage of research.

Who Are The Dominant Players Shaping The Mycoplasma Testing Market Landscape?

Major companies operating in the mycoplasma testing market are Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Roche Diagnostics International AG, Charles River Laboratories International Inc., Nelson Laboratories Fairfield Inc., Creative Bioarray, Biological Industries Israel Beit Haemek Ltd., Biotools B & M Labs S.A, PromoCell GmbH, American Type Culture Collection, Bionique Testing Laboratories Inc., InvivoGen, Clongen Laboratories LLC, Norgen Biotek Corporation, Gen Bio Sciences (P) Ltd., GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc.

Read the full mycoplasma testing market report here:

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Which Region Is Forecast To Lead The Mycoplasma Testing Market In Terms Of Market Size?

North America was the largest region in the mycoplasma testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the mycoplasma testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Mycoplasma Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=4103&type=smp

Browse Through More Reports Similar to the Global Mycoplasma Testing Market 2026, By The Business Research Company

Tuberculosis Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

Bactericide Global Market Report

https://www.thebusinessresearchcompany.com/report/bactericide-global-market-report

Amoxicillin Global Market Report

https://www.thebusinessresearchcompany.com/report/amoxicillin-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795